Health

This is to provide Latest HealthNews around the globe

  • ‘Mind-captioning’ technique can read human thoughts from brain scans

    Mind captioning. Credit: Science Advances (2025). DOI: 10.1126/sciadv.adw1464 Reading brain activity with advanced technologies is not a new concept. However, most techniques have focused on identifying single words associated with an object or action a person is seeing or thinking of, or matching up brain signals that correspond to spoken words. Some methods used caption databases or deep neural networks,…

    Read More »
  • It’s official – Vizz, the FDA-approved eye drops, allow reading without glasses and cost only $2 a day

    Presbyopia comes with age, and yes, it’s annoying. It forces you to stop reading, move your phone farther away, or turn on more light to read, and it seemed to have no solution other than glasses, but wait, because this might change your life if you suffer from it. It’s called Vizz, and it’s already been approved by the FDA.…

    Read More »
  • Your browser is not supported

    Your browser is not supported | providencejournal.com providencejournal.com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use. Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on providencejournal.com Source link

    Read More »
  • Why burning rosemary at home can help boost your wellbeing

    During the colder months of autumn and winter, some households have taken to burning this herb as a way to help purify the air and deter some pests. Additionally, it’s said to have some wellbeing benefits, helping improve concentration and maintain a calm state. Why burning this one item at home can help boost your wellbeing and deter pests Rosemary…

    Read More »
  • Using estimated risks and preferences to justify intensive BP control in CKD patients

    In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of <120 mm Hg compared with a target of <140 mm Hg. Thefindings will be presented at ASN Kidney Week…

    Read More »
  • HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

    Graphical Abstract: Schematic representation of 3-step HER2-targeted 225Ac-PRIT, 225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenograft, and representative histologic images of kidneys stained with hematoxylin and eosin, taken from treated mice at 175 days (top: untreated control; bottom: 2 x 225Ac-PRIT [37 kBq + 37 kBq]). Credit: S. Rinne et al. Weil Cornell Medicine, New York, NY. A…

    Read More »
  • Weight loss jab users on ‘King Kong’ issued severe warning about why it may not be working

    Menu News videos entertainment Home News UK News US News Australia Ireland World News Weird News Viral News Sport Technology Science True Crime Travel Entertainment Celebrity TV & Film Netflix Music Gaming TikTok LAD Originals FFS PRODUCTIONS Say Maaate to a Mate Daily Ladness UOKM8? FreeToBe Citizen Reef Categories Advertise Terms Privacy & Cookies LADbible Group UNILAD SPORTbible GAMINGbible Tyla…

    Read More »
  • Three health insurance companies drop out of Affordable Care Act marketplace in Michigan

    Three health insurance companies have all but completely dropped out of Michigan’s individual marketplace that’s part of the Affordable Care Act. Health Alliance Plan and Molina Healthcare will no longer offer ACA plans in the state, and Meridian Health Plan is sharply shrinking the geographic areas where it offers ACA plans. The announcements leave about 200,000 people scrambling to find…

    Read More »
  • U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

    Approved indication: KYGEVVI™ (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years.1 Survival benefit: Treatment reduced the overall risk of death from the start of treatment by approximately 86% (95% CI: 61%, 96%).1 Burden of disease: TK2d…

    Read More »
  • New radioimmunotherapy approach shows potential to cure HER2-positive breast cancer

    In an evolving health landscape, emerging research continues to highlight concerns that could impact everyday wellbeing. Here’s the key update you should know about: A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. The regimen, which pre-treats…

    Read More »
Back to top button
close